Literature DB >> 24582073

Reasons for hospitalization in Parkinson's disease: a case-control study.

Massimiliano Braga1, Massimo Pederzoli2, Angelo Antonini3, Francesca Beretta4, Vittorio Crespi2.   

Abstract

BACKGROUND: To characterize reasons for hospital admission, mortality and surgical procedures in patients with Parkinson's disease (PD) compared to controls.
METHODS: The clinical features of all consecutive patients from 2000 to 2007 were reviewed. We identified patients with PD (ICD 9 code 332.0) from a database of our General Hospital (Vimercate) with a catchment's population of 180,000. Data on admitting wards as well as reasons for admission, surgical procedures performed and clinical outcome were collected. Clinical data were compared to an age and sex matched control population admitted in the same period of time.
RESULTS: The total number of admissions was 367. Mean age was 76.7 years. The mean duration of stay was 9.2 days for controls and 9.7 for PD patients. A comorbid disorder was the cause of admission in 80% of cases and 79% of cases came from the Emergency Room. Infectious diseases, mainly respiratory infections, were more frequent in PD of both sexes, while trauma was significantly higher only in PD men. Percentage of patients treated surgically was similar in both cases and controls. Intrahospital mortality was 6% both in PD and controls. Infectious diseases were more frequent in PD patients while cardiovascular death was more frequent in controls.
CONCLUSIONS: Comorbidity in PD is higher than reported in other reports. In our study PD patients had the same length of hospitalization and intrahospital mortality as controls. The presence of a control population allows to discriminate between general complications of the elderly and specific vulnerabilities of PD patients.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Comorbidity; Hospitalization; Inpatient care; Parkinson's disease

Mesh:

Year:  2014        PMID: 24582073     DOI: 10.1016/j.parkreldis.2014.01.022

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

2.  Prevalence and Cumulative Incidence of Caregiver-Reported Aggression in Advanced Parkinson Disease and Related Disorders.

Authors:  Zachary A Macchi; Janis Miyasaki; Maya Katz; Nicholas Galifianakis; Stefan Sillau; Benzi M Kluger
Journal:  Neurol Clin Pract       Date:  2021-12

3.  Rate of Hospitalizations and Underlying Reasons Among People with Parkinson's Disease: Population-Based Cohort Study in UK Primary Care.

Authors:  Olaitan Okunoye; Laura Horsfall; Louise Marston; Kate Walters; Anette Schrag
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 4.  Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities.

Authors:  Margherita Fabbri; Miguel Coelho; Michela Garon; Roberta Biundo; Tiago A Mestre; Angelo Antonini
Journal:  J Pers Med       Date:  2022-05-18

5.  Fractures in Parkinson's Disease: injury patterns, hospitalization, and therapeutic aspects.

Authors:  René D Verboket; Laurent M Willems; Nils Mühlenfeld; Nicolas Söhling; Ingo Marzi; Martin Pieper; Esther Paule; Philipp S Reif; Adam Strzelczyk
Journal:  Eur J Trauma Emerg Surg       Date:  2019-10-14       Impact factor: 3.693

6.  Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients.

Authors:  Daniel Martinez-Ramirez; Juan C Giugni; Christopher S Little; John P Chapman; Bilal Ahmed; Erin Monari; Aparna Wagle Shukla; Christopher W Hess; Michael S Okun
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

7.  Trends in inpatient antiparkinson drug use in the USA, 2001-2012.

Authors:  James A G Crispo; Yannick Fortin; Dylan P Thibault; Matthew Emons; Lise M Bjerre; Dafna E Kohen; Santiago Perez-Lloret; Donald Mattison; Allison W Willis; Daniel Krewski
Journal:  Eur J Clin Pharmacol       Date:  2015-06-18       Impact factor: 2.953

Review 8.  Urinary Tract Infection in Parkinson's Disease.

Authors:  Elliot Hogg; Samuel Frank; Jillian Oft; Brian Benway; Mohammad Harun Rashid; Shouri Lahiri
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

9.  Measuring the Burden of Hospitalization in Patients with Parkinson´s Disease in Spain.

Authors:  Ruth Gil-Prieto; Raquel Pascual-Garcia; Jesus San-Roman-Montero; Pablo Martinez-Martin; Javier Castrodeza-Sanz; Angel Gil-de-Miguel
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

10.  Parkinson Matters.

Authors:  Sirwan K L Darweesh; Karen G Raphael; Patrik Brundin; Helen Matthews; Richard K Wyse; Honglei Chen; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.